Protagonist Therapeutics, Inc. earnings per share and revenue

PTGX earnings per share for the last quarter are 1.98 USD whereas the estimation was 1.39 USD which accounts for 42.60% surprise. Company revenue for the same period amounts to 170.64 M USD despite the estimated figure of 132.36 M USD. Estimated earnings per share for the next quarter are -0.03 USD, and revenue is expected to reach 39.92 M USD. Also watch annual changes over time to get a bigger picture of PTGX earnings per share and revenue dynamics.